索鲁普勒斯稳定无形分散剂用于提升费洛迪平的口服吸收
Shujuan Zhang1,2, Subing Xiong2, Ying Gong3
1Department of Biopharmaceutical, Lishui University, 1 Xueyuan Road, Lishui, 323000, China.
Current drug delivery
|January 17, 2025
概括
聚乙烯烯酸-聚乙烯-聚乙烯甘醇 (Soluplus) 稳定无形分散增强了口服药物输送. 与传统配方相比,费洛迪平无形分散剂显著改善了药物吸收.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 材料科学 材料科学 材料科学
背景情况:
- 小分子药物的水溶性较差,是制药开发中的一个重大障碍.
- 费洛迪平 (FLDP) 是一种重要的L型通道阻塞剂,具有较低的水溶性,限制了其口服生物利用性.
- 制定提高这种药物的溶解性和吸收性的策略对于有效的临床使用至关重要.
研究的目的:
- 调查Soluplus稳定无形分散剂在改善口服输送水溶性较差药物的有效性.
- 用Soluplus制备的费洛迪平载无形分散物的特性和性能.
- 评估新型药物输送系统的药物动力学概况.
主要方法:
- 通过双相混合方法制备Soluplus稳定型无形费洛迪平 (FLDP-SSAs).
- 使用偏光显微镜 (PLM),差分扫描热度计 (DSC),分子模拟和体外溶解研究进行表征.
- 在体内评估FLDP-SSAs的药理动力学.
主要成果:
- 通过PLM和DSC证实,FLDP-SSAs成功制备了无形性质,药物与Soluplus的比例为50:50.
- 在体外溶解研究表明,FLDP-SSAs产生纳米粒子 (~50 nm),与FLDP口服溶液相比,可溶性提高.
- 药物动力学评估显示,口服FLDP-SSAs与FLDP悬浮剂的曲线下的面积 (AUC) 增加了16.7倍.
结论:
- 索鲁普勒斯稳定无形分散物有效地稳定了非洛迪平在无形状态中的状态.
- 这些无形分散物作为有效的药物载体,显著增强了felodipine的口服吸收.
- 开发的配方有望提高水溶性较差的药物的治疗疗效.
相关概念视频
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
281
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
281
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
173
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
173
Factors Influencing Drug Absorption: Drug Dissolution
403
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
403
Factors Influencing Drug Absorption: Pharmaceutical Parameters
113
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
113
Factors Affecting Dissolution: Particle Size and Effective Surface Area
708
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
708
Factors Influencing Drug Absorption: Physicochemical Parameters
210
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
210


